IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.8 EUR
0 (0%)
Overall IVG gets a fundamental rating of 4 out of 10. We evaluated IVG against 109 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. IVG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
IVG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IVG has a Return On Assets (1.73%) which is in line with its industry peers.
IVG's Return On Equity of 12.39% is fine compared to the rest of the industry. IVG outperforms 73.39% of its industry peers.
IVG has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: IVG outperforms 43.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.86%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.17%, IVG is doing worse than 61.47% of the companies in the same industry.
In the last couple of years the Profit Margin of IVG has grown nicely.
With a Operating Margin value of 5.00%, IVG perfoms like the industry average, outperforming 41.28% of the companies in the same industry.
In the last couple of years the Operating Margin of IVG has grown nicely.
The Gross Margin of IVG (16.49%) is worse than 90.83% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
The number of shares outstanding for IVG has been increased compared to 5 years ago.
IVG has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG has a Altman-Z score of 1.77. This is comparable to the rest of the industry: IVG outperforms 41.28% of its industry peers.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IVG (14.82) is worse than 71.56% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
IVG has a Debt to Equity ratio of 1.35. This is amonst the worse of the industry: IVG underperforms 82.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.27%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a better Current ratio (1.98) than 73.39% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IVG (1.40) is better than 78.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased strongly by -23.43% in the last year.
Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -7.24% in the last year.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.03, the valuation of IVG can be described as correct.
Based on the Price/Earnings ratio, IVG is valued cheaper than 83.49% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.87, IVG is valued a bit cheaper.
IVG is valuated reasonably with a Price/Forward Earnings ratio of 8.72.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 91.74% of the companies listed in the same industry.
IVG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than the industry average as 77.06% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than 68.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.75 | ||
| EV/EBITDA | 5.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.76%, IVG has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.55, IVG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
BIT:IVG (1/6/2026, 5:36:15 PM)
18.8
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.10B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (6.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-3.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 | ||
| P/S | 0.34 | ||
| P/FCF | 12.75 | ||
| P/OCF | 3.96 | ||
| P/B | 1.96 | ||
| P/tB | 9.24 | ||
| EV/EBITDA | 5.57 |
EPS(TTM)1.34
EY7.13%
EPS(NY)2.16
Fwd EY11.47%
FCF(TTM)1.47
FCFY7.84%
OCF(TTM)4.75
OCFY25.28%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.27%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
What is the valuation status for IVG stock?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IVECO GROUP NV?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
How financially healthy is IVECO GROUP NV?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
Can you provide the expected EPS growth for IVG stock?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.